These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 34738774)

  • 1. A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache.
    Perrotta A; Biondi-Zoccai G; Saade W; Miraldi F; Morelli A; Marullo AG; Cavarretta E; Carnevale R; DE Falco E; Chimenti I; Sciarretta S; Frati P; Mamas MA; Ciardi S; Frati L; Frati G; Peruzzi M
    Panminerva Med; 2021 Sep; 63(3):324-331. PubMed ID: 34738774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-vaccination (COVID-19) impacts in healthcare personnel.
    Shahid S; Ghayyur A; Majeed A; Nisar S; Chaudary MA
    Pak J Pharm Sci; 2021 Sep; 34(5(Supplementary)):1957-1962. PubMed ID: 34836866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
    Song JY; Cheong HJ; Kim SR; Lee SE; Kim SH; Noh JY; Yoon YK; Choi WS; Park DW; Sohn JW; Kim WJ; Kim MJ
    J Korean Med Sci; 2021 Apr; 36(15):e110. PubMed ID: 33876589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
    Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S
    J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic.
    Ekizoglu E; Gezegen H; Yalınay Dikmen P; Orhan EK; Ertaş M; Baykan B
    Cephalalgia; 2022 Apr; 42(4-5):366-375. PubMed ID: 34510919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.
    Zhang MX; Zhang TT; Shi GF; Cheng FM; Zheng YM; Tung TH; Chen HX
    Expert Rev Vaccines; 2021 Jul; 20(7):891-898. PubMed ID: 33929930
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-vaccination incidence and side effects of COVID-19 in a cohort of Brazilian healthcare professionals: an internet-based survey.
    Ballestero M; Souza RLP; Sakae TM; Costa LGVD; Furlanetti L; Oliveira RS
    Einstein (Sao Paulo); 2022; 20():eAO0067. PubMed ID: 36449755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events occurring post-covid-19 vaccination among healthcare professionals - A mixed method study.
    Mahapatra S; Nagpal R; Marya CM; Taneja P; Kataria S
    Int Immunopharmacol; 2021 Nov; 100():108136. PubMed ID: 34587578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccination experience among United States dental professionals and students: Safety, confidence, concerns, and side effects.
    Bsoul EA; Loomer PM
    PLoS One; 2022; 17(2):e0264323. PubMed ID: 35192657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Headache following vaccination against COVID-19 among healthcare workers with a history of COVID-19 infection: a cross-sectional study in Iran with a meta-analytic review of the literature.
    Nasergivehchi S; Togha M; Jafari E; Sheikhvatan M; Shahamati D
    Head Face Med; 2023 May; 19(1):19. PubMed ID: 37202794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study.
    Islam MR; Hasan M; Nasreen W; Tushar MI; Bhuiyan MA
    Int J Immunopathol Pharmacol; 2021; 35():20587384211065628. PubMed ID: 34911394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh.
    Alam ABMM; Azim Majumder MA; Haque M; Ashraf F; Khondoker MU; Mashreky SR; Wahab A; Siddiqui TH; Uddin A; Joarder T; Ahmed SMM; Deeba F; Nessa K; Rahman S; Jahan I; Islam Z; Adnan N; E-Murshid M; Islam S; Urmi UL; Yusuf A; Sarkar NC; Mallik TS; Raza AMS; Daud AKM; Razzaque MS
    Expert Rev Vaccines; 2021 Sep; 20(9):1167-1175. PubMed ID: 34224292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects of COVID-19 vaccines among Iranian healthcare workers: a retrospective cohort study.
    Roudgari H; Etemad K; Karami M; Mostafavi F; Sotoodeh Ghorbani S; Farhadi Babadi K; Rahimi E; Taherpour N; Fattahi Masoom SM; Habibi M; Kermanpour H; Laripour R; Manoochehri O; Raeeszadeh M; Salimi A; Shekarchi B; Tajernia A; Zafarghandi MR; Zali A; Zarghi A; Hashemi Nazari SS
    J Infect Dev Ctries; 2024 Apr; 18(4):532-541. PubMed ID: 38728645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
    Sharif N; Alzahrani KJ; Ahmed SN; Dey SK
    Front Immunol; 2021; 12():714170. PubMed ID: 34707602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous adverse events following 771 doses of the inactivated and mRNA COVID-19 vaccines: A survey study among health care providers.
    Bostan E; Yel B; Karaduman A
    J Cosmet Dermatol; 2022 Sep; 21(9):3682-3688. PubMed ID: 35775860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
    Zare H; Rezapour H; Mahmoodzadeh S; Fereidouni M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108351. PubMed ID: 34801416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.